Climb Bio, Inc.
CLYM
$2.33
-$0.15-6.05%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 27.16% | -540.10% | -110.42% | -76.15% | -42.80% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -89.29% | 3,278.45% | 426.56% | 510.85% | 345.99% |
| Change in Net Operating Assets | -87.51% | 12.31% | -54.89% | -22.16% | 450.00% |
| Cash from Operations | -69,675.44% | -302.94% | 24.45% | 60.90% | 100.16% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -321.78% | -324.80% | -268.81% | -156.52% | 172.53% |
| Cash from Investing | -336.84% | -330.84% | -275.54% | -166.51% | 155.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.02% | 15,217.43% | 15,474.20% | 23,584.63% | 516,832.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -98.21% | 15,188.19% | 15,444.47% | 23,584.63% | 516,832.00% |
| Foreign Exchange rate Adjustments | 115.22% | 2.22% | -86.18% | -109.44% | -123.10% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -201.32% | -207.67% | -111.88% | 314.88% | 2,807.25% |